LifeMD vs SBC Medical
LFMD and SBC side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LFMD and SBC compare
SBC Medical is the larger company, worth 6.3 times as much as LifeMD ($539M against $85.8M).
LifeMD grew revenue faster over the last twelve months (3.8% versus −6.9% for SBC Medical).
SBC Medical keeps more of each dollar of sales as profit, with a net margin of 28.0% compared with 0.12% at LifeMD.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LFMD | SBC |
|---|---|---|
| Size and price | ||
| Market cap | $85.8M | $539M |
| Share price | $1.78 | $5.24 |
| Change, 1 year | −65.3% | 53.2% |
| Change, 5 years | −60.8% | – |
| Beta (5Y) | 1.71 | 0.44 |
| Employees | 389 | 863 |
| StockData Score | ||
| Total score | 12 | 12 |
| Valuation score | 2 | 4 (better) |
| Growth score | 3 (better) | 0 |
| Performance score | 3 | 3 |
| Health score | 4 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 11.1× |
| P/S | 0.5× (better) | 3.1× |
| P/B | 10.8× | 2.0× (better) |
| EV/EBITDA | – | 5.4× |
| P/FCF | – | 8.7× |
| FCF yield | −12.9% | 11.5% (better) |
| Fair value | $2.38 | $8.64 |
| Margin of safety | 25.3% | 39.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 3.8% (better) | −6.9% |
| Revenue growth, 5Y average | 39.1% | – |
| Net income growth (TTM) | – | 47.1% |
| EPS growth (TTM) | – | 46.9% |
| Profitability | ||
| Gross margin | 86.1% (better) | 71.9% |
| Operating margin | −14.7% | 37.3% (better) |
| Net margin | 0.12% | 28.0% (better) |
| FCF margin | −6.7% | 35.3% (better) |
| Return on equity | 6.5% | 19.3% (better) |
| Return on invested capital | – | 50.7% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 (better) |
| Net debt / EBITDA | – | −2.69 |
| Interest coverage | – | 195× |
| Current ratio | 0.90 | 3.31 (better) |
| Altman Z-score | −3.44 | 4.95 (better) |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Payout ratio | 1545% | – |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 44.9% | 8.3% |
| Held by insiders | 18.2% | 82.0% |
| Insider net buying, 12 months | −$54.1K (better) | −$20.1M |
Go deeper
- LFMD stock overview
- LFMD income statement
- LFMD valuation and score
- SBC stock overview
- SBC income statement
- SBC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.